Nasdaq mrsn.
Nov 29, 2023 · Mersana Therapeutics, Inc. (NASDAQ:MRSN) posted its quarterly earnings results on Tuesday, November, 7th. The company reported ($0.35) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.31) by $0.04. The firm had revenue of $7.70 million for the quarter, compared to the consensus estimate of $9.30 million.
That number of contracts represents approximately 1.5 million underlying shares, working out to a sizeable 117.2% of MRSN's average daily trading volume over the past month, of 1.3 million shares.CAMBRIDGE, Mass., July 19, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc.(NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on... Mersana Therapeutics Announces Partial ...Jan 19, 2023 · That number of contracts represents approximately 1.5 million underlying shares, working out to a sizeable 117.2% of MRSN's average daily trading volume over the past month, of 1.3 million shares. RADNOR, Pa., June 15, 2020 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of...To find the current corn price per bushel, there are a number of websites and places to look for predictions about the commodities market. Corn prices are listed on sites like NASDAQ and AgWeb if you want a quick answer.
The stock price of Mersana Therapeutics Inc (NASDAQ: MRSN) has surged by 3.92 when compared to previous closing price of 1.53, but the company has seen a 0.63% gain in its stock price over the last five trading sessions. GlobeNewsWire reported 2023-10-31 that CAMBRIDGE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) — Mersana …
Oct 9, 2023 · Payments resumed on October 1 for the first time since March 2020. Before the pandemic, the federal government was collecting about $5.8 billion in payments each month. A recent report from the ...
Dec 4, 2023 · MRSN Earnings Date and Information. Mersana Therapeutics last announced its earnings data on November 7th, 2023. The reported ($0.35) earnings per share for the quarter, missing the consensus estimate of ($0.31) by $0.04. The company had revenue of $7.70 million for the quarter, compared to analyst estimates of $9.30 million. CAMBRIDGE, Mass., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company …Citigroup upgraded its rating of Mersana Therapeutics MRSN to Buy with a price target of $5.00, changing its price target from $1.00 to $5.00. Shares of Mersana Therapeutics are trading up 5.26% ...View real-time MRSN stock price and news, along with industry-best analysis. ... Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet, Dow Jones. ETF Movers: Includes ETFs & ETNs with ...
On April 28, 2023, among the underlying components of the Nasdaq, Unusual Whales saw unusual or noteworthy options trading volume and activity in Mersana Therapeutics (MRSN) 8/18 C $5.00.
Stock analysis for Mersana Therapeutics Inc (MRSN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
CAMBRIDGE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...CAMBRIDGE, Mass., June 12, 2019 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (Nasdaq: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...View real-time MRSN stock price and news, along with industry-best analysis. ... Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet, Dow Jones. ETF Movers: Includes ETFs & ETNs with ...Mersana Therapeutics, Inc. (NASDAQ: MRSN) was in 25 hedge funds' portfolios at the end of March. The all time high for this statistic is 30. Our calculations also showed that MRSN isn't among the ...CAMBRIDGE, Mass., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company …
Analyst Price Forecast Suggests 93.56% Upside. As of May 11, 2023, the average one-year price target for Mersana Therapeutics is 15.64. The forecasts range from a low of 12.12 to a high of $21.00 ...RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today ...Nov 24, 2023 · Shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Free Report) have earned a consensus rating of “Reduce” from the seven research firms that are currently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation and six have issued a hold recommendation on the company. The average 1 […] The forecasts range from a low of 12.12 to a high of $21.00. The average price target represents an increase of 315.70% from its latest reported closing price of 3.88. See our leaderboard of ...CAMBRIDGE, Mass., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...Nov 30, 2023 · The stock price of Mersana Therapeutics Inc (NASDAQ: MRSN) has surged by 3.92 when compared to previous closing price of 1.53, but the company has seen a 0.63% gain in its stock price over the last five trading sessions. GlobeNewsWire reported 2023-10-31 that CAMBRIDGE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ: […]
CAMBRIDGE, Mass., Feb. 28, 2020 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...
Nov 7, 2023 · Mersana Therapeutics Inc (NASDAQ:MRSN) trade information. Instantly MRSN has showed a red trend with a performance of -2.11% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.4950 on Monday, 11/06/23 increased the stock’s daily price by 7.02%. Dec 4, 2023 · Mersana Therapeutics Inc (NASDAQ:MRSN) trade information. Sporting 15.15% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on Friday, 12/01/23 when the MRSN stock price touched $1.90 or saw a rise of 10.38%. In the world of clinical-stage biopharmaceutical companies, Mersana Therapeutics, Inc (NASDAQ:MRSN) is a name that is hard to miss. As one of the pioneering companies in the development of antibody-drug conjugates for the benefit of cancer patients, Mersana Therapeutics’ ground-breaking research and innovation have earned it a high degree of recognition and appreciation.Find the latest Earnings Report Date for Marinus Pharmaceuticals, Inc. Common Stock (MRNS) at Nasdaq.com.Adc Therapeutics SA (ADCT) shares have gone down -62.70% during the last six months, with a year-to-date growth rate less than the industry average at -19.60% against 15.30. Yet analysts are ramping up their growth forecast for the fiscal year 2023. Revenue is predicted to shrink -50.00% this quarter and then jump 33.80% in the quarter after that.Mersana Therapeutics Stock Price, News & Analysis (NASDAQ:MRSN) $1.59 +0.06 (+3.92%) (As of 11/29/2023 ET) Compare Today's Range $1.52 $1.60 50 …Martin Huber. Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet needs. The company develops XMT-1660, a B7-H4-targeted Dolasynthen ADC candidate; and XMT-2056, an immunosynthen ADC. It has a research and development collaborations with Janssen Biotech ...
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q3 2023 Earnings Call Transcript November 7, 2023 Mersana Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-0.31 ...
CAMBRIDGE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...
Asset Growth. 23.24%. Trailing 12-Months. The Mersana Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system ... Citigroup upgraded its rating of Mersana Therapeutics MRSN to Buy with a price target of $5.00, changing its price target from $1.00 to $5.00. Shares of Mersana Therapeutics are trading up 5.26% ...CAMBRIDGE, Mass., May 24, 2023 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...Mersana Therapeutics Inc (MRSN) Stock Price & News - Google Finance. Home MRSN • NASDAQ. Mersana Therapeutics Inc. Follow. Share. $1.59. After Hours: $1.56. (1.89%) -0.030.Mersana Therapeutics, Inc. Common Stock (MRSN) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.Real time Mersana Therapeutics (MRSN) stock price quote, stock graph, news & analysis. Real time Mersana Therapeutics (MRSN) stock price quote, stock graph, news & analysis. A high-level overview of Mersana Therapeutics, Inc. (MRSN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.CAMBRIDGE, Mass., April 07, 2020 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (Nasdaq: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...CAMBRIDGE, Mass., Dec. 22, 2022 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...A high-level overview of Mersana Therapeutics, Inc. (MRSN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Mersana Therapeutics Inc (NASDAQ:MRSN)’s traded shares stood at 0.41 million during the last session, with the company’s beta value hitting 1.31. At the close of trading, the stock’s price was $1.55, to imply an increase of 3.68% or $0.05 in intraday trading. The MRSN share’s 52-week high ...
CAMBRIDGE, Mass., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...Mersana Therapeutics, Inc. Common Stock (MRSN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.CAMBRIDGE, Mass., April 05, 2022 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...Mersana Therapeutics Inc. MRSN (U.S.: Nasdaq). AT CLOSE 4:00 PM EST 12/01/23. $1.90USD; 0.2515.15%. Volume3,085,773. AFTER HOURS 7:37 PM EST 12/01/23. $ ...Instagram:https://instagram. how to buy walmart stockswhere to sell my websitecost to retire in belizeandrew tate the real world app Mersana Therapeutics Inc (NASDAQ:MRSN) Mersana Therapeutics Inc. Real-Time Quotes. 1.86. BATS BZX Real-Time Price. As of 11:12am ET. +0.265 / +16.67%. Today’s Change. 0.80.Find the latest Earnings Report Date for Mersana Therapeutics, Inc. Common Stock (MRSN) at Nasdaq.com. barings bdcshould i buy bonds now or wait The stock price of Mersana Therapeutics Inc (NASDAQ: MRSN) has surged by 3.92 when compared to previous closing price of 1.53, but the company has seen a 0.63% gain in its stock price over the last five trading sessions. GlobeNewsWire reported 2023-10-31 that CAMBRIDGE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ: […]Mersana Therapeutics Inc (NASDAQ: MRSN) has experienced a rise in its stock price by 15.15 compared to its previous closing price of 1.65. However, the company has seen a gain of 19.50% in its stock price over the last five trading days. GlobeNewsWire reported 2023-10-31 that CAMBRIDGE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) — Mersana ... ria consulting 6.26%. $31.54M. AcelRx Pharmaceuticals Inc. 2.87%. $11.12M. MRNS | Complete Marinus Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full ...View real-time MRSN stock price and news, along with industry-best analysis. ... Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet, Dow Jones. ETF Movers: Includes ETFs & ETNs with ...